Comparative statistics by cancer registry

Registry: Comparative statistics by cancer site

Table1: Data quality indices - Proportion (%) of histologically verified and death certificate only cases, number and proportion of included and excluded cases by site

(Mumbai, India, 1992-1994 cases followed through 1999 and 1995-1999 cases followed-up until 2003)

Click on cancer site (ICD-10 code) for comparison
%No. of excluded casesIncluded cases
SiteICD-10Total registeredHVDCODCONo. follow-upOthersTotal%No.%
C00Lip16886.33.052074.216195.8
C01-02Tongue224083.85.11151451346.0210694.0
C03-06Oral cavity289586.13.81091701264.4276995.6
C09Tonsil54883.46.03320356.451393.6
C10Other oropharynx25783.75.11301145.424394.6
C11Nasopharynx25476.84.31100114.324395.7
C12-13Hypopharynx196984.12.754121673.4190296.6
C15Oesophagus364761.213.749817451914.2312885.8
C16Stomach246665.99.824114626110.6220589.4
C18Colon171172.47.01191131337.8157892.2
C19-20Rectum129975.75.97660826.3121793.7
C21Anus23784.04.21007177.222092.8
C25Pancreas108940.815.21653417215.891784.2
C32Larynx215169.712.02596627112.6188087.4
C33-34Lung399562.613.051818854413.6345186.4
C50Breast775183.55.240434194575.9729494.1
C53Cervix468384.94.420532102475.3443694.7
C56Ovary215175.15.1110571225.7202994.3
C60Penis33581.81.860282.432797.6
C61Prostate162271.69.1148831599.8146390.2
C62Testis39485.52.51010112.838397.2
C64Kidney85783.84.03431384.481995.6
C67Urinary bladder140377.56.38835966.8130793.2
C81Hodgkin lymphoma53799.40.631591.752898.3
C82-85+C96Non-Hodgkin lymphoma236299.60.24182241.0233899.0
C91Lymphoid leukaemia110499.90.113150.5109999.5
C92-94Myeloid leukaemia127699.70.3492151.2126198.8
C95Leukaemia unspecified35198.31.760061.734598.3


Other tables available for this registry:
- Table1: Data quality indices - Proportion (%) of histologically verified and death certificate only cases, number and proportion of included and excluded cases by site (Mumbai, India, 1992-1994 cases followed through 1999 and 1995-1999 cases followed-up until 2003)
- Table2a: Number and proportion of cases with complete/incomplete follow-up and median follow-up (in months) by site (Mumbai, India, 1992-1994 cases followed through 1999 and 1995-1999 cases followed-up until 2003)
- Table3: Comparison of 1-, 3- and 5-year absolute and relative survival and 5-year age-standardized relative survival (ASRS) by site (Mumbai, India, 1992-1994 cases followed through 1999 and 1995-1999 cases followed-up until 2003)
- Table4: Site-wise number of cases, 5-year absolute and relative survival by sex and relative survival by age group (Mumbai, India, 1992-1994 cases followed through 1999 and 1995-1999 cases followed-up until 2003)
- Table5b: Proportion (%) of cases and 5-year absolute survival by extent of disease and site (Mumbai, India, 1992-1999)
- Table6: Comparison of 5-year absolute and relative survival of cases diagnosed between 1982-1986 and 1992-1999 (Mumbai, India)




Registry chapter:


Consult the chapter in Cancer survival in developping countries (Volume II)